Author

J. El Bakali

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:bacteria (other)· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:protein structure prediction· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. G. Coyne· 2 shared C. Abell· 2 shared M. V. B. Dias· 2 shared T. L. Blundell· 2 shared A. Hammer· 1 shared C. Spry· 1 shared G. A. L. Zuniga· 1 shared G. S. de Oliveira· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

A. G. Coyne

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Chemical validation of Mycobacterium tuberculosis phosphopantetheine adenylyltransferase using fragment linking and CRISPR interference

J. El Bakali, M. Blaszczyk, J. C. Evans, J. A. Boland, W. J. McCarthy, M. V. B. Dias, A. G. Coyne, V. Mizrahi, T. L. Blundell, C. Abell, C. Spry

This study identifies inhibitors of MtbPPAT, a key enzyme in CoA biosynthesis, using fragment linking and CRISPR interference to validate it as a potential anti-TB drug target.

bioRxiv · Sep 4, 2020Biochemistry

Using a fragment-based approach to identify novel chemical scaffolds targeting the dihydrofolate reductase (DHFR) from Mycobacterium tuberculosis

J. A. Ribeiro, A. Hammer, G. A. L. Zuniga, S. M. Chavez-Pacheco, P. Tyrakis, G. S. de Oliveira, T. Kirkman, J. El Bakali, S. A. Rocco, M. L. Sforca, R. Parise-Filho, A. G. Coyne, T. L. Blundell, C. Abell, M. V. B. Dias

This study uses fragment-based drug discovery to identify novel chemical scaffolds targeting Mycobacterium tuberculosis DHFR, revealing a new binding mode and low micromolar affinity compounds.

bioRxiv · Mar 30, 2020Biochemistry